2001 Origin: Teamed with Shandong Lukang Pharmaceutical to set up Qingdao branches and New Specialty Drugs branches.
2005 Start: Established Qingdao Lujian Pharmaceutical Industry Company.
2018 Transformation: Launched Lujian Health Technology, focusing on R&D and incubation of health industry projects.
2019 Positioning: Formed a medical device company and a strategic partnership with Tongrentang (Shandong).
2020 Investment: Invested in high-tech medical equipment - surgical robots.
2021 Expansion: Expanded externally, integrating industry and finance, and promoted high-tech medical product transformation and production.
2022 Focus: Registered with Israel's IIA and introduced the Israeli Troclose project - trocar with automatic port closure.
2023 Strategy: Visited domestic and international high-tech firms and discussed about product cooperation. Focused on building a surgery cluster and established an incubation center.
2024 Innovation: Successfully transitioned production to domestic alternatives, achieved independent R & D and industrial innovation.